The President of UNITE signs statement in support of the World Health Organization (WHO) Pandemic Agreement
The Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) publish new guiding principles for the use of large language models (LLMs) in regulatory affairs.
Victoria Goff has been announced as the new Editor-in-Chief of Regulatory Rapporteur.
The new draft guidance from NICE states that Lecanemab is ‘not recommended’ and the EMA has recommended the refusal of the marketing authorisation for Leqembi.
Five children with hereditary deafness have had their hearing restored in both ears through gene therapy in a clinical trial.
Vol.21 #6: In June 2024’s RegRapPod, host Alan Booth talks to Issue Editor Davina Stevenson about access to medicines
BONUS EPISODE: In Conversation talking sustainability with Bengt Mattson